• Biohaven Pharmaceuticals

Children Can Get Migraines Too

Migraine headaches can be debilitating in children but often go undiagnosed because children have a more difficult time understanding and expressing their pain. View the video below to hear the Salinas family talk about their experience with the disorder.

Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 12 and 18 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.

Recent Posts

See All